Literature DB >> 9336425

Criteria for the diagnosis of familial Mediterranean fever.

A Livneh1, P Langevitz, D Zemer, N Zaks, S Kees, T Lidar, A Migdal, S Padeh, M Pras.   

Abstract

OBJECTIVE: To establish a new set of criteria for the diagnosis of familial Mediterranean fever (FMF).
METHODS: Twenty-seven features and manifestations typical of FMF were studied to determine their prevalence in 105 patients with FMF and 106 controls. Diagnosis of FMF in the study group was based on clinical judgment. Controls were patients with a variety of other diseases who presented to the emergency room or outpatient clinics with recurrent episodes of pain in body sites usually involved in FMF attacks. Manifestations observed to be significantly more common in FMF patients than in controls were incorporated into the rule proposed for diagnosis of FMF, based on a model of major, minor, and supportive criteria.
RESULTS: Two sets of diagnostic criteria were established. A conservative criteria set for diagnosis of FMF was based on the presence of 1 major or 2 minor criteria, or 1 minor plus 5 supportive criteria, and a simple criteria set for diagnosis of FMF required 1 major or 2 minor criteria. The sensitivity and specificity of these 2 criteria sets were >95% and >97%, respectively.
CONCLUSION: The proposed new sets of criteria were highly sensitive and specific, and could be used to readily diagnose FMF and to distinguish FMF from other periodic febrile diseases.

Entities:  

Mesh:

Year:  1997        PMID: 9336425     DOI: 10.1002/art.1780401023

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  385 in total

1.  High factor VIII levels during attacks of familial Mediterranean fever.

Authors:  Nejat Akar; Mesíha Ekím; Ceyda Gürman
Journal:  Pediatr Nephrol       Date:  2004-05-04       Impact factor: 3.714

2.  Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF).

Authors:  Udi Nussinovitch; Avi Livneh; Benjamin Volovitz; Moshe Nussinovitch; Ilan Ben-Zvi; Merav Lidar; Naomi Nussinovitch
Journal:  Clin Rheumatol       Date:  2012-04-18       Impact factor: 2.980

3.  Autoinflammatory disorders and patients with isolated serosal involvement.

Authors:  Luca Cantarini; Orso Maria Lucherini; Rolando Cimaz; Maria Giuseppina Brizi; Mauro Galeazzi
Journal:  Rheumatol Int       Date:  2010-05-22       Impact factor: 2.631

4.  Mediterranean fever (MEFV) gene mutation frequency is not increased in adults with rheumatic heart disease.

Authors:  Ismail Simsek; Cem Koz; Nurcan Basar; Ismail Sari; Hakan Erdem; Salih Pay; Bunyamin Kisacik; Muhterem Bahce; Ayhan Dinc
Journal:  Clin Rheumatol       Date:  2010-07-20       Impact factor: 2.980

Review 5.  Autoinflammatory Syndromes in Children.

Authors:  Ruth J Pepper; Helen J Lachmann
Journal:  Indian J Pediatr       Date:  2016-01-29       Impact factor: 1.967

6.  Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine.

Authors:  Chagai Grossman; Itzhak Farberov; Olga Feld; Avi Livneh; Ilan Ben-Zvi
Journal:  Rheumatol Int       Date:  2019-01-02       Impact factor: 2.631

7.  Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity.

Authors:  Sema Haliloglu; Ayse Carlioglu; Derya Akdeniz; Yasar Karaaslan; Ali Kosar
Journal:  Rheumatol Int       Date:  2014-03-04       Impact factor: 2.631

Review 8.  Non-canonical manifestations of familial Mediterranean fever: a changing paradigm.

Authors:  Donato Rigante; Giuseppe Lopalco; Giusyda Tarantino; Adele Compagnone; Michele Fastiggi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-03-13       Impact factor: 2.980

Review 9.  Familial Mediterranean fever and glomerulonephritis and review of the literature.

Authors:  Tekin Akpolat; Ilkser Akpolat; Filiz Karagoz; Engin Yilmaz; Bedri Kandemir; Seza Ozen
Journal:  Rheumatol Int       Date:  2003-06-27       Impact factor: 2.631

Review 10.  Familial Mediterranean fever.

Authors:  Aysin Bakkaloglu
Journal:  Pediatr Nephrol       Date:  2003-06-27       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.